Stock Movers

On this episode of Stock Movers:
-Vertiv Holdings Co. (VRT) now expects 2026 sales to almost triple since 2021 as it benefits from soaring demand for data center equipment. The company raised its revenue and earnings outlook after third-quarter sales came in 15% stronger than analysts expected and organic orders more than doubled.
-GE Healthcare (GEHC) jumps after the maker of X-ray equipment boosted its adjusted earnings per share guidance for the full year and posted results for the third quarter that beat the average analyst estimate.
-Boston Scientific (BSX) shares slump after the medical-device maker gave an adjusted earnings per share guidance for the full year that fell short of the average analyst estimate.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Vertiv Holdings (VRT) shares surge. The maker of power and cooling equipment raised its full-year adjusted earnings per share outlook to above consensus estimates. CEO Giordano Albertazzi said in a statement that organic order growth was more than 100% as its role in the data center boom “keeps expanding.”
- NXP Semiconductors (NXPI) shares slide. The chipmaker forecast revenue growth that raised concerns a recovery in demand from the auto industry is stalling. Fourth-quarter sales are set to rise about 15% to roughly $3.85 billion, which compares with an average analyst estimate of $3.87 billion. The company's results were described as "just OK" by analyst Joshua Buchalter, who said NXP may not be benefiting from increasing demand from carmakers in the same way that peers have shown.
- Enphase Energy (ENPH) shares fell as much as 20%, the most since June 2025, after fourth-quarter guidance from the solar energy equipment manufacturer missed the average analyst estimate. Analysts note that recovery now looks delayed into 2027 and that the macro environment is weakening across all geographies.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Robinhood (HOOD) is declining after the brokerage reported third-quarter earnings per share that missed consensus estimates.
- Etsy (ETSY) shares are gaining after the online retail company reported third-quarter results that beat expectations on key metrics. It also announced that its CFO Lanny Baker will depart to pursue opportunities outside of Etsy.
- Wendy's (WEN) shares are moving on news Nelson Peltz's hedge fund Trian Fund Management is offering to buy Wendy's for around $1.4 billion.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- GE Vernova (GEV) shares are gaining after the maker of power generation equipment boosted its revenue forecast for the full year. The company also said it would pay $9 billion to acquire grid equipment supplier Trench Group.
- SY Hynix (KS) shares are moving after it unveiled plans to return about $45 billion more to shareholders after profit surged a stronger-than-expected seven-fold. The company expects shortages of memory chip components to persist through at least 2030 and will invest heavily in expanding capacity.
- Robinhood (HOOD) is declining after the brokerage reported third-quarter earnings per share that missed consensus estimates.Eric Mollo
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Standard Chartered shares gain as much as 5.2% in London, the most in three months, after the Asia-focused lender delivered third-quarter results ahead of expectations and raised its full-year guidance. Analysts highlight broad-based strength across the banking group, with consensus earnings estimates expected to rise by low to mid-single digits.
- Stellantis NV stuck to its guidance for the year as the struggling carmaker fights to reduce costs, improve quality and roll out new models to counter intensifying competition particularly in Europe.
- GSK Plc’s third-quarter profit report showed slumping vaccine sales, causing the biggest share plunge since April.
See omnystudio.com/listener for privacy information.